Sfoglia per Autore
Low-level Bcr-Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib
2011 Soverini S; Gnani A; De Benedittis C; Castagnetti F; Gugliotta G; Iacobucci I; Palandri F; Rosti G; Testoni N; Luatti S; Marzocchi G; Baccarani M; Martinelli G
Drug Resistance and Bcr-Abl Kinase Domain Mutations In Philadelphia-Positive Acute Lymphoblastic Leukemia From the Imatinib to the 2nd-Generation Tyrosine Kinase Inhibitor Era: The Main Changes Are In the Type of Mutations, but Not In the Frequency of Mutation Involvement
2011 S Soverini; A Gnani; C De Benedittis; I Iacobucci; A Lonetti; C Papayannidis; L Potenza; M Luppi; S Merante; M Malagola; D Russo; M Tiribelli; M Salvucci; A Zaccaria; B Giannini; G Poletti; A Vitale; L Elia; M Vignetti; R Foà; M Baccarani; G Martinelli
Ultra-Deep Amplicon Sequencing Using Roche 454 Technology Allows High Sensitivity Bcr-Abl Kinase Domain Mutation Screening and Anticipates Emerging Mutations Leading to Resistance to Tyrosine Kinase Inhibitors in Philadelphia-Positive Leukemia Patients
2011 Soverini S; De Benedittis C; Gnani A; Iacobucci I; Russo D; Cattina F; Castagnetti F; Gugliotta G; Papayannidis C; Vitale A; Elia L; Foà R; Palandri F; Lonetti A; Bochicchio MT; Durante S; Rosti G; Baccarani M; Martinelli G
Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies
2011 Soverini S.; Gnani A.; De Benedittis C.; Castagnetti F.; Gugliotta G.; Bochicchio MT.; Palandri F.; Arpinati M.; Bonifazi F.; Abruzzese E.; Sorà F.; Alimena G.; Pregno P.; Specchia G.; Russo D.; Pane F.; Saglio G.; Salvucci M.; Zaccaria A.; Poletti G.; Giannini B.; Iacobucci I.; Lonetti A.; Durante S.; Rosti G.; Baccarani M.; Martinelli G.
Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications
2012 Simona Soverini, Caterina De Benedittis, Katerina Machova Polakova, Adela Brouckova, Fausto Castagnetti, Cristina Papayannidis, Gabriele Gugliotta, Francesca Palandri, Hana Klamova, Ilaria Iacobucci, Claudia Venturi, Federica Cattina, Paola Bresciani, Valeria Coluccio, Marzia Salvucci, Mario Tiribelli, Gianni Binotto, Tamara Intermesoli, Mario Luppi, Maria Teresa Bochicchio, Emanuela Ottaviani, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Giovanni Martinelli
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse.
2012 Cristina Papayannidis, Paola Fazi, Alfonso Piciocchi, Francesco Di Raimondo, Giovanni Pizzolo, Angelo Michele Carella, Mario Cazzola, Antonio Cuneo, Pietro Leoni, Mario Luppi, Enrica Morra, Giorgina Specchia, Emanuele Angelucci, Monica Bocchia, Renato Fanin, Giuseppe Saglio, Daniele Vallisa, Sandra De Simone, Antonella Vitale, Ilaria Iacobucci, Simona Soverini, Anna Ferrari, Claudia Venturi, Caterina De Benedittis, Nicoletta Testoni, Antonio Curti, Stefania Paolini, Miriam Fogli, Giovanni Martinelli, Michele Baccarani
Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology
2012 Soverini S; De Benedittis C; Gnani A; Iacobucci I; Castagnetti F; Gugliotta G; Papayannidis C; Cattina F; Russo D; Pantaleo MA; Rosti G; Baccarani M; Martinelli G
Ultradeep-Amplicon Pyrosequencing for Mutation Detection in the Kinase Domain of BCR-ABL Revealed Artificial Low-Level Variants That Need to Be Avoided for Relevant Mutational Data Interpretation
2012 Adela Brouckova; Simona Soverini; Caterina De Benedittis; Hana Klamova; Cyril Salek; Marek Trneny; Michele Baccarani; Giovanni Martinelli; Katerina Machova Polakova
Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain Allows Earlier Detection and More Accurate Characterization of Resistant Subclones in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Receiving Tyrosine Kinase Inhibitor-Based Therapies
2012 Simona Soverini, Caterina De Benedittis, Katerina Machova Polakova, Adela Brouckova, Cristina Papayannidis, Paola Bresciani, Valeria Coluccio, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Federica Cattina, Robin Foà, Antonella Vitale, Domenico Russo, Michele Baccarani, Giovanni Martinelli
Bcr-Abl kinase domain mutations and resistance in Ph+ acute lymphoblastic leukemia from the imatinib to the 2nd-generation TKI era
2012 SOVERINI S.; GNANI A.; CATERINA DE BENEDITTIS C.; IACOBUCCI I.; VENTURI C.; PAPAYANNIDIS C.; LUPPI M.; MERANTE S.; MALAGOLA M.; RUSSO D.; TIRIBELLI M.; SALVUCCI M.; VITALE A.; ELIA L.; VIGNETTI M.; FOÀ R.; BACCARANI M.; MARTINELLI G.
High Sensitivity Mutation Screening and Clonal Analysis Allowed by Ultra-Deep Amplicon Sequencing Uncover the Complexity of Bcr-Abl Mutation Status in Patients Treated with Tyrosine Kinase Inhibitors
2012 S Soverini; C De Benedittis; F Cattina; A Broucková; K Machová Poláková; D Russo; A Gnani; I Iacobucci; MT Bochicchio; F Castagnetti; G Gugliotta; F Palandri; C Papayannidis; H Klamová; A Vitale; M Vignetti; R Foà; G Rosti; M Baccarani; G Martinelli
Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications
2012 Simona Soverini; Caterina De Benedittis; Katerina Machova Polakova; Adela Brouckova; Fausto Castagnetti; Cristina Papayannidis; Gabriele Gugliotta; Francesca Palandri; Hana Klamova; Ilaria Iacobucci; Claudia Venturi; Federica Cattina; Paola Bresciani; Valeria Coluccio; Marzia Salvucci; Mario Tiribelli; Gianni Binotto; Tamara Intermesoli; Mario Luppi; Maria Teresa Bochicchio; Emanuela Ottaviani; Domenico Russo; Gianantonio Rosti; Michele Baccarani; Giovanni Martinelli
High Sensitivity Mutation Monitoring and Clonal Analysis by Ultra-Deep Amplicon Sequencing Uncover the Complexity of BCR-ABL Mutation Status in Philadelphia+ Patients Treated with Tyrosine Kinase Inhibitors
2012 Soverini S.; De Benedittis C.; Castagnetti F.; Papayannidis C.;Gugliotta G.; Iacobucci I.; Venturi C.; Bochicchio MT.; Cattina F.; Russo D.; Rosti G.; Baccarani M.; Martinelli G.
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse
2012 Papayannidis, Cristina; Paola, Fazi; Alfonso, Piciocchi; Francesco, Di Raimondo; Giovanni, Pizzolo; Angelo Michele, Carella; Mario, Cazzola; Antonio, Cuneo; Pietro, Leoni; Mario, Luppi; Enrica, Morra; Giorgina, Specchia; Emanuele, Angelucci; Monica, Bocchia; Renato, Fanin; Giuseppe, Saglio; Daniele, Vallisa; Sandra, De Simone; Antonella, Vitale; Iacobucci, Ilaria; Soverini, Simona; Ferrari, Anna; Venturi, Claudia; DE BENEDITTIS, Caterina; Testoni, Nicoletta; Curti, Antonio; Paolini, Stefania; Fogli, Miriam; Martinelli, Giovanni; Baccarani, Michele
PKC412 (Midostaurin) Is Safe and Highly Effective in Systemic Mastocytosis Patients: The Bologna Experience
2012 Cristina Papayannidis, Mariachiara Abbenante, Sarah Parisi, Stefania Paolini, Ilaria Iacobucci, Federica Frabetti, Emanuela Ottaviani, Anna Ferrari, Viviana Guadagnuolo, Chiara Sartor, Simona Soverini, Caterina De Benedittis, Carmen Baldazzi, Nicoletta Testoni, Michele Baccarani, Giovanni Martinelli
Deep sequencing of the BCR-ABL kinase domain reveals a frequency of 35INS insertion/truncation higher than expected
2013 De Benedittis C, Soverini S, Machova Polakova K, Brouckova A, Castagnetti F, Gugliotta G, Palandri F, Papayannidis C, Klamova H, Bresciani P, Coluccio V, Salvucci M, Tiribelli M, Binotto G, Intermesoli T, Iacobucci I, Venturi C, Luppi M, Ottaviani E, MT Bochicchio, Cattina F, Mancini M, Elisa L, Haferlach T, Kohlmann A, Russo D, Rosti G, Baccarani M, Cavo M, Martinelli G.
Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain
2013 Caterina De Benedittis, Simona Soverini, Katerina Machova Polakova, Adela Brouckova, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Hana Klamova, Paola Bresciani, Marzia Salvucci, Gianni Binotto, Tamara Intermesoli, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Maria Teresa Bochicchio, Manuela Mancini, Elisa Leo, Torsten Haferlach, Alexander Kohlmann, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli
Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain
2013 Caterina De Benedittis, Simona Soverini, Katerina Machova Polakova, Adela Brouckova, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Hana Klamova, Paola Bresciani, Marzia Salvucci, Gianni Binotto, Tamara Intermesoli, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Maria Teresa Bochicchio, Manuela Mancini, Elisa Leo, Torsten Haferlach, Alexander Kohlmann, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli
Ponatinib Is Well Tolerated and Active In Patients With Relapsed/Refractory Philadelphia Positive Acute Lymphoblastic Leukemia (PH+ ALL) and Advanced Phase Of Chronic Myelogenous Leukemia (CML) Harbouring T315I Mutation: The Bologna Experience
2013 Cristina Papayannidis, Caterina De Benedittis, Simona Soverini, Ilaria Iacobucci, Maria Chiara Abbenante, Chiara Sartor, Maria Teresa Bochicchio, Anna Ferrari, Claudia Venturi, Valentina Robustelli, Andrea Ghelli Luserna Di Rorà, Viviana Guadagnuolo, Emanuela Ottaviani, Nicoletta Testoni, Carmen Baldazzi, Simona Luatti, Sarah Parisi, Stefania Paolini, Cristina Clissa, Alberto Conficoni, Federica Frabetti, Elisa Lani, Silvia Piccari, Paolo Di Bartolomeo, Roberto Di Lorenzo, Renato Fanin, Giuseppe Cimino, Giovanni Martinelli
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain.
2013 Soverini S; De Benedittis C; Machova Polakova K; Brouckova A; Horner D; Iacono M; Castagnetti F; Gugliotta G; Palandri F; Papayannidis C; Iacobucci I; Venturi C; Bochicchio MT; Klamova H; Cattina F; Russo D; Bresciani P; Binotto G; Giannini B; Kohlmann A; Haferlach T; Roller A; Rosti G; Cavo M; Baccarani M; Martinelli G.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Low-level Bcr-Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib | Soverini S; Gnani A; De Benedittis C; Castagnetti F; Gugliotta G; Iacobucci I; Palandri F; Rosti ...G; Testoni N; Luatti S; Marzocchi G; Baccarani M; Martinelli G | 2011-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
Drug Resistance and Bcr-Abl Kinase Domain Mutations In Philadelphia-Positive Acute Lymphoblastic Leukemia From the Imatinib to the 2nd-Generation Tyrosine Kinase Inhibitor Era: The Main Changes Are In the Type of Mutations, but Not In the Frequency of Mutation Involvement | S Soverini; A Gnani; C De Benedittis; I Iacobucci; A Lonetti; C Papayannidis; L Potenza; M Luppi;... S Merante; M Malagola; D Russo; M Tiribelli; M Salvucci; A Zaccaria; B Giannini; G Poletti; A Vitale; L Elia; M Vignetti; R Foà; M Baccarani; G Martinelli | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
Ultra-Deep Amplicon Sequencing Using Roche 454 Technology Allows High Sensitivity Bcr-Abl Kinase Domain Mutation Screening and Anticipates Emerging Mutations Leading to Resistance to Tyrosine Kinase Inhibitors in Philadelphia-Positive Leukemia Patients | Soverini S; De Benedittis C; Gnani A; Iacobucci I; Russo D; Cattina F; Castagnetti F; Gugliotta G...; Papayannidis C; Vitale A; Elia L; Foà R; Palandri F; Lonetti A; Bochicchio MT; Durante S; Rosti G; Baccarani M; Martinelli G | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies | Soverini S.; Gnani A.; De Benedittis C.; Castagnetti F.; Gugliotta G.; Bochicchio MT.; Palandri F....; Arpinati M.; Bonifazi F.; Abruzzese E.; Sorà F.; Alimena G.; Pregno P.; Specchia G.; Russo D.; Pane F.; Saglio G.; Salvucci M.; Zaccaria A.; Poletti G.; Giannini B.; Iacobucci I.; Lonetti A.; Durante S.; Rosti G.; Baccarani M.; Martinelli G. | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications | Simona Soverini, Caterina De Benedittis, Katerina Machova Polakova, Adela Brouckova, Fausto Casta...gnetti, Cristina Papayannidis, Gabriele Gugliotta, Francesca Palandri, Hana Klamova, Ilaria Iacobucci, Claudia Venturi, Federica Cattina, Paola Bresciani, Valeria Coluccio, Marzia Salvucci, Mario Tiribelli, Gianni Binotto, Tamara Intermesoli, Mario Luppi, Maria Teresa Bochicchio, Emanuela Ottaviani, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Giovanni Martinelli | 2012-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse. | Cristina Papayannidis, Paola Fazi, Alfonso Piciocchi, Francesco Di Raimondo, Giovanni Pizzolo, An...gelo Michele Carella, Mario Cazzola, Antonio Cuneo, Pietro Leoni, Mario Luppi, Enrica Morra, Giorgina Specchia, Emanuele Angelucci, Monica Bocchia, Renato Fanin, Giuseppe Saglio, Daniele Vallisa, Sandra De Simone, Antonella Vitale, Ilaria Iacobucci, Simona Soverini, Anna Ferrari, Claudia Venturi, Caterina De Benedittis, Nicoletta Testoni, Antonio Curti, Stefania Paolini, Miriam Fogli, Giovanni Martinelli, Michele Baccarani | 2012-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology | Soverini S; De Benedittis C; Gnani A; Iacobucci I; Castagnetti F; Gugliotta G; Papayannidis C; Ca...ttina F; Russo D; Pantaleo MA; Rosti G; Baccarani M; Martinelli G | 2012-01-01 | CANCER RESEARCH | American Association of Cancer Research | 4.02 Riassunto (Abstract) | - |
Ultradeep-Amplicon Pyrosequencing for Mutation Detection in the Kinase Domain of BCR-ABL Revealed Artificial Low-Level Variants That Need to Be Avoided for Relevant Mutational Data Interpretation | Adela Brouckova; Simona Soverini; Caterina De Benedittis; Hana Klamova; Cyril Salek; Marek Trneny...; Michele Baccarani; Giovanni Martinelli; Katerina Machova Polakova | 2012-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain Allows Earlier Detection and More Accurate Characterization of Resistant Subclones in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Receiving Tyrosine Kinase Inhibitor-Based Therapies | Simona Soverini, Caterina De Benedittis, Katerina Machova Polakova, Adela Brouckova, Cristina Pap...ayannidis, Paola Bresciani, Valeria Coluccio, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Federica Cattina, Robin Foà, Antonella Vitale, Domenico Russo, Michele Baccarani, Giovanni Martinelli | 2012-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
Bcr-Abl kinase domain mutations and resistance in Ph+ acute lymphoblastic leukemia from the imatinib to the 2nd-generation TKI era | SOVERINI S.; GNANI A.; CATERINA DE BENEDITTIS C.; IACOBUCCI I.; VENTURI C.; PAPAYANNIDIS C.; LUPP...I M.; MERANTE S.; MALAGOLA M.; RUSSO D.; TIRIBELLI M.; SALVUCCI M.; VITALE A.; ELIA L.; VIGNETTI M.; FOÀ R.; BACCARANI M.; MARTINELLI G. | 2012-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
High Sensitivity Mutation Screening and Clonal Analysis Allowed by Ultra-Deep Amplicon Sequencing Uncover the Complexity of Bcr-Abl Mutation Status in Patients Treated with Tyrosine Kinase Inhibitors | S Soverini; C De Benedittis; F Cattina; A Broucková; K Machová Poláková; D Russo; A Gnani; I Iaco...bucci; MT Bochicchio; F Castagnetti; G Gugliotta; F Palandri; C Papayannidis; H Klamová; A Vitale; M Vignetti; R Foà; G Rosti; M Baccarani; G Martinelli | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications | Simona Soverini; Caterina De Benedittis; Katerina Machova Polakova; Adela Brouckova; Fausto Casta...gnetti; Cristina Papayannidis; Gabriele Gugliotta; Francesca Palandri; Hana Klamova; Ilaria Iacobucci; Claudia Venturi; Federica Cattina; Paola Bresciani; Valeria Coluccio; Marzia Salvucci; Mario Tiribelli; Gianni Binotto; Tamara Intermesoli; Mario Luppi; Maria Teresa Bochicchio; Emanuela Ottaviani; Domenico Russo; Gianantonio Rosti; Michele Baccarani; Giovanni Martinelli | 2012-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
High Sensitivity Mutation Monitoring and Clonal Analysis by Ultra-Deep Amplicon Sequencing Uncover the Complexity of BCR-ABL Mutation Status in Philadelphia+ Patients Treated with Tyrosine Kinase Inhibitors | Soverini S.; De Benedittis C.; Castagnetti F.; Papayannidis C.;Gugliotta G.; Iacobucci I.; Ventur...i C.; Bochicchio MT.; Cattina F.; Russo D.; Rosti G.; Baccarani M.; Martinelli G. | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse | Papayannidis, Cristina; Paola, Fazi; Alfonso, Piciocchi; Francesco, Di Raimondo; Giovanni, Pizzol...o; Angelo Michele, Carella; Mario, Cazzola; Antonio, Cuneo; Pietro, Leoni; Mario, Luppi; Enrica, Morra; Giorgina, Specchia; Emanuele, Angelucci; Monica, Bocchia; Renato, Fanin; Giuseppe, Saglio; Daniele, Vallisa; Sandra, De Simone; Antonella, Vitale; Iacobucci, Ilaria; Soverini, Simona; Ferrari, Anna; Venturi, Claudia; DE BENEDITTIS, Caterina; Testoni, Nicoletta; Curti, Antonio; Paolini, Stefania; Fogli, Miriam; Martinelli, Giovanni; Baccarani, Michele | 2012-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
PKC412 (Midostaurin) Is Safe and Highly Effective in Systemic Mastocytosis Patients: The Bologna Experience | Cristina Papayannidis, Mariachiara Abbenante, Sarah Parisi, Stefania Paolini, Ilaria Iacobucci, F...ederica Frabetti, Emanuela Ottaviani, Anna Ferrari, Viviana Guadagnuolo, Chiara Sartor, Simona Soverini, Caterina De Benedittis, Carmen Baldazzi, Nicoletta Testoni, Michele Baccarani, Giovanni Martinelli | 2012-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
Deep sequencing of the BCR-ABL kinase domain reveals a frequency of 35INS insertion/truncation higher than expected | De Benedittis C, Soverini S, Machova Polakova K, Brouckova A, Castagnetti F, Gugliotta G, Palandr...i F, Papayannidis C, Klamova H, Bresciani P, Coluccio V, Salvucci M, Tiribelli M, Binotto G, Intermesoli T, Iacobucci I, Venturi C, Luppi M, Ottaviani E, MT Bochicchio, Cattina F, Mancini M, Elisa L, Haferlach T, Kohlmann A, Russo D, Rosti G, Baccarani M, Cavo M, Martinelli G. | 2013-01-01 | HAEMATOLOGICA | - | 1.06 Abstract in rivista | - |
Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain | Caterina De Benedittis, Simona Soverini, Katerina Machova Polakova, Adela Brouckova, Fausto Casta...gnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Hana Klamova, Paola Bresciani, Marzia Salvucci, Gianni Binotto, Tamara Intermesoli, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Maria Teresa Bochicchio, Manuela Mancini, Elisa Leo, Torsten Haferlach, Alexander Kohlmann, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli | 2013-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain | Caterina De Benedittis, Simona Soverini, Katerina Machova Polakova, Adela Brouckova, Fausto Casta...gnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Hana Klamova, Paola Bresciani, Marzia Salvucci, Gianni Binotto, Tamara Intermesoli, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Maria Teresa Bochicchio, Manuela Mancini, Elisa Leo, Torsten Haferlach, Alexander Kohlmann, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli | 2013-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
Ponatinib Is Well Tolerated and Active In Patients With Relapsed/Refractory Philadelphia Positive Acute Lymphoblastic Leukemia (PH+ ALL) and Advanced Phase Of Chronic Myelogenous Leukemia (CML) Harbouring T315I Mutation: The Bologna Experience | Cristina Papayannidis, Caterina De Benedittis, Simona Soverini, Ilaria Iacobucci, Maria Chiara Ab...benante, Chiara Sartor, Maria Teresa Bochicchio, Anna Ferrari, Claudia Venturi, Valentina Robustelli, Andrea Ghelli Luserna Di Rorà, Viviana Guadagnuolo, Emanuela Ottaviani, Nicoletta Testoni, Carmen Baldazzi, Simona Luatti, Sarah Parisi, Stefania Paolini, Cristina Clissa, Alberto Conficoni, Federica Frabetti, Elisa Lani, Silvia Piccari, Paolo Di Bartolomeo, Roberto Di Lorenzo, Renato Fanin, Giuseppe Cimino, Giovanni Martinelli | 2013-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain. | Soverini S; De Benedittis C; Machova Polakova K; Brouckova A; Horner D; Iacono M; Castagnetti F; ...Gugliotta G; Palandri F; Papayannidis C; Iacobucci I; Venturi C; Bochicchio MT; Klamova H; Cattina F; Russo D; Bresciani P; Binotto G; Giannini B; Kohlmann A; Haferlach T; Roller A; Rosti G; Cavo M; Baccarani M; Martinelli G. | 2013-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile